Joshua T. Kantrowitz, MD

Board Certifications: 
Psychiatry
Accepting New Patients
Profile Headshot

Overview

Academic Appointments

  • Assistant Professor of Clinical Psychiatry

Hospital Affiliations

  • NewYork-Presbyterian/Columbia
  • NewYork-Presbyterian/The Allen Hospital

Gender

  • Male

Location(s)

CUMC/Herbert Pardes Building of the New York State Psychiatric Institute
1051 Riverside Drive
New York, NY 10032
Primary

Credentials & Experience

Education & Training

  • State University of New York - Downstate Health Sciences Center
  • Residency: Yale-New Haven Hospital
  • Fellowship: State Psychiatric Institute

Board Certifications

  • Psychiatry

Research

Grants

A PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFECT OF A SINGLE DOSE OF CVN058 ON MISMATCH NEGATIVITY IN SUBJECTS WITH STABLE SCHIZOPHRENIA (P&S Industry Clinical Trial)

Oct 5 2018 - Oct 5 2023

EARLY CORTICAL PROCESSING IN SCHIZOPHRENIA (Federal Gov)

Sep 27 2018 - Jun 30 2023

A RANDOMIZED, SINGLE-BLIND, PARALLEL GROUP STUDY TO EVALUATE THE EFFECTS OF TS-134 ON KETAMINE-INDUCED BOLD SIGNALS IN RESTING FMRI IN HEALTHY ADULT SUBJECTS. (P&S Industry Clinical Trial)

Nov 21 2017 - Nov 21 2020

HUMAN TRIAL OF ALLOSTERIC MODULATOR ALPHA7 NICOTINIC RECEPTORS IN SCHIZOPHRENIA (Federal Gov)

Sep 1 2016 - Aug 31 2018

HUMAN TRIAL OF ALLOSTERIC MODULATOR ALPHA7 NICOTINIC RECEPTORS IN SCHIZOPHRENIA (Federal Gov)

Sep 1 2016 - Aug 31 2017

FAST-PS TORFP - BIOMARKER VALIDATION STUDY (Federal Gov)

Aug 29 2015 - Apr 28 2017

BH4 TREATMENT IN SCHIZOPHRENIA (Private)

Feb 15 2011 - Nov 30 2015

MEASURING QUALITY OF TRANSCRANIAL MAGNETIC SIMULATION (NY State Gov)

Jan 1 2012 - Mar 31 2015

NEW EXPERIMENTAL MEDICINE STUDIES FAST-FAIL IN TRIALS IN PSYCHOTIC SPECTRUM DISORDERS (FAST-PS) (Federal Gov)

Aug 29 2013 - Sep 28 2014